Intron-A/Aldara combination therapy for BCC

Journal of Drugs in Dermatology, Feb, 2008

Sponsored by: The University of Texas Health Science Center, Houston. The purpose of this study is to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron[R]-A and Aldara[R].

Condition             Intervention            Phase

Basal Cell Carcinoma  Biological: Imiquimod   Phase IV
  Excluding Scalp       and Interferon alpha
  and Face

Study ID Numbers: HSC-MS-06-0478, OSP-24412

ClinicalTrials.gov Identifier: NCT00581425